Clinical Ink, a pharma-focused mobile clinical trial data collection company, has raised $4.3 million. FCA Venture partners led the round, with additional funding from 10 undisclosed angel investors.

New research opens the door for more streamlined and patient-centric protocols, informed by benchmarking analysis of phase II and III protocol procedures The research assesses how protocol design ...

Pharma-focused mobile clinical trial data collection company Clinical Ink has merged with CentrosHealth, formerly MyHealthBook, which makes configurable mobile apps for clinical trial patient ...

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the enrollment of the first patient in the new PPD™ CorEvitas™ Myasthenia Gravis (MG) Registry. This nationwide ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...

In the early 2000s, Paul Harris, a research informatics faculty member and bioengineer at Vanderbilt University Medical Center, noticed a pressing problem. While working with research teams, he found ...

McKesson's QCDR status allows direct data submission to CMS via iKnowMed EHR, enhancing oncology practice efficiency. Practice Insights supports reporting of nine oncology-specific QCDR measures, ...